Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million PIPE financing.
March 09, 2026
GRAIL stock plunged nearly 50% in premarket trading after its NHS-Galleri cancer trial missed its primary endpoint.
February 20, 2026
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.
Back to tokenist.com
467 free spots remaining
By reading Five Minute Finance each week, I learn about new trends before anyone else. I can’t emphasize enough how valuable that is.
Isaiah B.
Five Minute Finance has influenced how I see finance - I rely on it for insight on the latest news and trends at the intersection of finance and technology.
Monica P.